State Of Wisconsin Investment Board Beyond Spring Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $2.66 $30,509 - $71,820	-27,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.68 - $5.01 $71,736 - $213,927	-42,700 Reduced 61.26%	27,000 $59,000
Q4 2021 Feb 11, 2022	BUY	$4.02 - $16.84 $193,763 - $811,688	48,200 Added 224.19%	69,700 $316,000
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $199,090 - $673,165	21,500 New	21,500 $339,000
Q2 2021 Aug 12, 2021	SELL	$9.37 - $12.12 $165,849 - $214,524	-17,700 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$10.21 - $17.31 $22,462 - $38,082	-2,200 Reduced 11.06%	17,700 $216,000
Q1 2020 May 06, 2020	BUY	$9.68 - $18.47 $36,784 - $70,186	3,800 Added 23.6%	19,900 $255,000
Q3 2019 Nov 12, 2019	BUY	$15.33 - $23.85 $246,813 - $383,985	16,100 New	16,100 $291,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $67M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.